ASSESSMENT OF THE CLOPIDOGREL ACTION WITH REGARD TO CYP2C19 GENE POLYMORPHISMS IN PATIENTS WITH CORONARY ARTERY DISEASE AFTER IMPLANTATION OF DES STENTS

J. K. Uzokov; B. A. Alyavi; A. X. Abdullaev

Евразийский Кардиологический Журнал (Jun 2019)

ASSESSMENT OF THE CLOPIDOGREL ACTION WITH REGARD TO CYP2C19 GENE POLYMORPHISMS IN PATIENTS WITH CORONARY ARTERY DISEASE AFTER IMPLANTATION OF DES STENTS

J. K. Uzokov,
B. A. Alyavi,
A. X. Abdullaev

Affiliations

J. K. Uzokov: Republican specialized scientific practical medical center of therapy medical rehabilitation
B. A. Alyavi: Republican specialized scientific practical medical center of therapy medical rehabilitation
A. X. Abdullaev: Republican specialized scientific practical medical center of therapy medical rehabilitation

Journal volume & issue: Vol. 0, no. 2S

Abstract

Read online

Aim of the work to assess the impact of CYP2C19 polymorphisms, including those of CYP2C19*1, CYP2C19*2, CYP2C19*3 and CYP2C19*17 on clopidogrel response variability in patients undergoing percutaneous coronary intervention (PCI) following DES implantation.

Published in Евразийский Кардиологический Журнал

ISSN: 2225-1685 (Print); 2305-0748 (Online)
Publisher: InterMedservice
Country of publisher: Russian Federation
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.heartj.asia/

About the journal